In conclusion, the present findings provide detailed insights into dynamic endocrine changes in persons with obesity following metabolic surgery by linking reversal of the dysregulation of the GH-IGF-1 axis to adipose tissue metabolism and function. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.